Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The study record now shows a new document revision (Revision: v3.5.4) and indicates a Redacted CSR Synopsis, with the prior revision (v3.5.3) removed.
    Difference
    0.2%
    Check dated 2026-05-18T03:31:04.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    This updates the displayed interface/version identifier on the page (revision v3.5.0 → v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:18:44.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Waldenström macroglobulinemia, Richter syndrome, and B-cell chronic lymphocytic leukemia to the conditions section, and updated site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-28T22:45:07.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now displays revision number v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T12:46:49.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no other changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:28:52.000Z thumbnail image
  9. Check
    120 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.4.0 to v3.4.1 (added v3.4.1 and removed v3.4.0).
    Difference
    0.1%
    Check dated 2026-02-06T10:43:21.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.